Ketamine Dose-Dependently Induces High-Frequency Oscillations in the Nucleus Accumbens in Freely Moving Rats

Biological Psychiatry

Volumn 60, Issue 11, 2006, Pages 1206-1214

  Hunt, Mark Jeremy ^a   Raynaud, Beryl ^a   Garcia, Rene ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

high frequency oscillations; Ketamine; local field potentials; locomotion; nucleus accumbens; schizophrenia

Indexed keywords

DEXAMPHETAMINE; KETAMINE;

ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; HIGH FREQUENCY OSCILLATION; HYPERACTIVITY; LOCOMOTION; MALE; MOVEMENT (PHYSIOLOGY); NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ACTION POTENTIALS; ANIMALS; AROUSAL; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HIGH-FREQUENCY VENTILATION; KETAMINE; MALE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 33750604942     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.01.020     Document Type: Article

References (50)

1. Abi-Saab W.M., D'Souza D.C., Moghaddam B., and Krystal J.H. The NMDA antagonist model for schizophrenia: Promise and pitfalls. Pharmacopsychiatry 31 suppl 2 (1998) 104-109
2. Adams B., and Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18 (1998) 5545-5554
3. Adler C.M., Malhotra A.K., Elman I., Goldberg T., Egan M., Pickar D., and Breier A. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry 156 (1999) 1646-1649
4. Becker A., Peters B., Schroeder H., Mann T., Huether G., and Grecksch G. Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 687-700
5. Bleuler E. In: Zinkin J. (Ed). Dementia Praecox or the Group of Schizophrenia (1911), International University Press, New York, NY trans.
6. Buzsaki G., Leung L.W., and Vanderwolf C.H. Celular bases of hippocampal EEG in the behaving rat. Brain Res 287 (1983) 139-171
7. Carlezon Jr. W.A., and Wise R.A. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16 (1996) 3112-3122
8. Chambers R.A., Krystal J.H., and Self D.W. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50 (2001) 71-83
9. Chrobak J.J., and Buzsaki G. High-frequency oscillations in the output networks of the hippocampal-entorhinal axis of the freely behaving rat. J Neurosci 16 9 (1996) 3056-3066
10. Collins R.J., Weeks J.R., Cooper M.M., Good P.I., and Russell R.R. Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology (Berl) 82 (1984) 6-13
11. Crider R. Phencyclidine: Changing abuse patterns. NIDA Res Monogr 64 (1986) 163-173
12. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85 (1988) 5274-5278
13. Duncan G.E., Miyamoto S., Leipzig J.N., and Lieberman J.A. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: Support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Res 843 (1999) 171-183
14. Erhardt S., Blennow K., Nordin C., Skogh E., Lindstrom L.H., and Engberg G. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313 (2001) 96-98
15. Finch D.M. Neurophysiology of converging synaptic inputs from the rat prefrontal cortex, amygdala, midline thalamus, and hippocampal formation onto single neurons of the caudate/putamen and nucleus accumbens. Hippocampus 6 (1996) 495-512
16. Fine J., and Finestone S.C. Sensory disturbances following ketamine anesthesia: Recurrent hallucinations. Anesth Analg 52 (1973) 428-430
17. Foffani G., Priori A., Egidi M., Rampini P., Tamma F., Caputo E., et al. 300-Hz subthalamic oscillations in Parkinson's disease. Brain 126 (2003) 2153-1563
18. Gray J.A. Integrating schizophrenia. Schizophr Bull 24 (1998) 249-266
19. Hammer Jr. R.P., and Herkenham M. Altered metabolic activity in the cerebral cortex of rats exposed to ketamine. J Comp Neurol 220 (1983) 396-404
20. Hunt M.J., Kessal K., and Garcia R. Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats. J Neurosci 25 (2005) 524-531
21. Jackson M.E., Homayoun H., and Moghaddam B. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci USA 101 (2004) 8467-8484
22. Jodo E., Suzuki Y., Takeuchi S., Niwa S., and Kayama Y. Different effects of phencyclidine and methamphetamine on firing activity of medial prefrontal cortex neurons in freely moving rats. Brain Res 962 (2003) 226-231
23. Jones M.S., and Barth D.S. Spatiotemporal organization of fast (> 200 Hz) electrical oscillations in rat Vibrissa/Barrel cortex. J Neurophysiol 82 (1999) 1599-1609
24. Kapur S., and Seeman P. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry 7 (2002) 837-844
25. Kessal K., Chessel A., Spennato G., and Garcia R. Ketamine and amphetamine both enhance synaptic transmission in the amygdala-nucleus accumbens pathway but with different time-courses. Synapse 57 (2005) 61-65
26. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51 (1994) 199-214
27. Lahti A.C., Koffel B., LaPorte D., and Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13 (1995) 9-19
28. Liddle P.F., Friston K.J., Frith C.D., Hirsch S.R., Jones T., and Frackowiak R.S. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 160 (1992) 179-186
29. Malhotra A.K., Pinals D.A., Adler C.M., Elman I., Clifton A., Pickar D., and Breier A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17 (1997) 141-150
30. Mansbach R.S. Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur J Pharmacol 202 (1991) 61-66
31. Masimore B., Kakalios J., and Redish A.D. Measuring fundamental frequencies in local field potentials. J Neurosci Methods 138 (2004) 97-105
32. McGowan S., Lawrence A.D., Sales T., Quested D., and Grasby P. Presynaptic dopaminergic dysfunction in schizophrenia: A positron emission tomographic [18F]fluorodopa study. Arch Gen Psychiatry 61 (2004) 134-142
33. Melega W.P., Williams A.E., Schmitz D.A., DiStefano E.W., and Cho A.K. Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 274 (1995) 90-96
34. Miyamoto S., Leipzig J.N., Lieberman J.A., and Duncan G.E. Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice. Neuropsychopharmacology 22 (2000) 400-412
35. Moghaddam B., Adams B., Verma A., and Daly D. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17 (1997) 2921-2927
36. Ngan E.T., Lane C.J., Ruth T.J., and Liddle P.F. Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naive schizophrenic patients: Correlations with symptom change. J Neurol Neurosurg Psychiatry 72 (2002) 106-110
37. O'Donnell P., and Grace A.A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: Hippocampal gating of prefrontal cortical input. J Neurosci 15 (1995) 3622-3639
38. O'Donnell P., and Grace A.A. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr Bull 24 (1998) 267-283
39. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33 (1999) 523-533
40. Paxinos W., and Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed (1986), Academic Press, San Diego
41. Phillips G.D., Robbins T.W., and Everitt B.J. Bilateral intra-accumbens self-administration of damphetamine: Antagonism with intra-accumbens SCH-23390 and sulpiride. Psychopharmacology (Berl) 114 (1994) 477-485
42. Ponomarenko A.A., Korotkova T.M., and Haas H.L. High frequency (200 Hz) oscillations and firing patterns in the basolateral amygdala and dorsal endopiriform nucleus of the behaving rat. Behav Brain Res 141 (2003) 123-129
43. Risterucci C., Jeanneau K., Schoppenthau S., Bielser T., Kunnecke B., von Kienlin M., and Moreau J.L. Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia. Psychopharmacology (Berl) 180 (2005) 724-734
44. Sams-Dodd F. Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav Pharmacol 6 (1995) 55-65
45. Schwarcz R., Rassoulpour A., Wu H.Q., Medoff D., Tamminga C.A., and Roberts R.C. Increased cortical kynurenate content in schizophrenia. Biol Psychiatry 50 (2001) 521-530
46. Silbersweig D.A., Stern E., Frith C., Cahill C., Holmes A., Grootoonk S., et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 378 (1995) 176-179
47. Spencer K.M., Nestor P.G., Niznikiewicz M.A., Salisbury D.F., Shenton M.E., and McCarley R.W. Abnormal neural synchrony in schizophrenia. J Neurosci 23 (2003) 7407-7411
48. Spencer K.M., Nestor P.G., Perlmutter R., Niznikiewicz M.A., Klump M.C., Frumin M., et al. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A 101 (2004) 17288-17293
49. Suzuki Y., Jodo E., Takeuchi S., Niwa S., and Kayama Y. Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats. Neuroscience 114 (2002) 769-779
50. Ylinen A., Bragin A., Nadasdy Z., Jando G., Szabo I., Sik A., and Buzsaki G. Sharp wave-associated high-frequency oscillation (200 Hz) in the intact hippocampus: network and intracellular mechanisms. J Neurosci 15 (1995) 30-46